Cancer treatment: Patients treated with sunitinib and sorafenib respond to flu vaccine
Tuesday, June 28, 2011 - 14:30
in Health & Medicine
Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared, according to a new study.
